Analyst Recommendations

53.16 0.39(0.74%)10/04/2024
Crinetics Pharmaceuticals Inc (CRNX)


2024: Total Recommendations Consensus
To Grade# of Recommendations
Buy11
Overweight8
Market Outperform7
Outperform7

5 records were shown. To view all data, Upgrade to PRO plan with only $1


Upgrades & Downgrades